New agents for treatment of systemic fungal infections
- 1 July 2000
- journal article
- Published by Taylor & Francis in Emerging Drugs
- Vol. 5 (2), 135-160
- https://doi.org/10.1517/14728214.5.2.135
Abstract
Systemic antifungal chemotherapy is enjoying its most dynamic era. More antifungal agents are under development than ever before, including agents in entirely new classes. Major goals of current investigations are to identify compounds with a wide spectrum of activity, minimal toxicity and a high degree of target specificity. The antifungal drugs in development include new azoles (voriconazole, posaconazole (formerly SCH56592), ravuconazole [formerly BMS-207147]), lipid formulations of amphotericin B, a lipid formulation of nystatin, echinocandins (VER-002 [formerly, LY303366], caspofungin [formerly MK-991], FK463), antifungal peptides other than echinocandins and sordarin derivatives. This discussion reviews the currently available antifungal agents and summarises the developmental issues that surround these new systemic antifungal drugs.Keywords
This publication has 137 references indexed in Scilit:
- Amphotericin B colloidal dispersionExpert Opinion on Pharmacotherapy, 2000
- Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.Diagnostic Microbiology and Infectious Disease, 1998
- Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiationBone Marrow Transplantation, 1998
- Anaphylactic reactions to liposomal amphotericinThe Lancet, 1994
- Clinical Pharmacokinetics of FluconazoleClinical Pharmacokinetics, 1993
- Liposomal and Lipid Formulations of Amphotericin BClinical Pharmacokinetics, 1992
- Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Systemically Administered Antifungal AgentsDrugs, 1992
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Infection in cancer patients: A continuing associationAmerican Journal Of Medicine, 1986